Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Pykus Therapeutics completes trial enrollment for PYK-2101, a novel retinal sealant for the treatment of retinal detachment

Illinois Retina Associates and Rush University Medical Center. "Eliminating the need for intraocular gas would be transformative for patients undergoing vitrectomy, addressing a significant source of patient anxiety." "We are thrilled to complete...

To expand biopharma services with its liquid biopsy capabilities, Precision for Medicine partners with SOPHiA GENETICS on the SOPHiA DDM™ platform

and precision medicine services. As part of this collaboration, Precision for Medicine will integrate the SOPHiA DDM™ Platform for biomarker discovery, clinical trial assays (CTAs), and advanced algorithms to expand clinical trial capabilities....

IFF Pharma Solutions launches METHOCEL™ HPMC with low nitrite content to mitigate nitrosamine risks

hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages. This innovative product line addresses the industry’s concern with nitrosamine...

SciTech Development announces the second FDA approval of a Phase 1 A/B IND for ST-001, which now targets the treatment of relapsed/refractory small cell lung cancer, following its previous approval for the treatment of T-cell NHL

is Greg Kalemkerian, MD, a renowned thoracic oncologist at the University of Michigan. "Small cell lung cancer remains a formidable challenge with few effective therapies for patients who relapse or don't respond to initial treatment," said Dr....

Connected Pill Box Unveiled by Hello Heart to Radically Improve Medication Adherence

of Hello Heart. “But the status quo won’t get us there — we need innovation. We will continue building on our platform with products like Hello Heart Pill Box to engage people in their heart health like never before.” About Hello Heart: Hello Heart...

Emerald Clinical Trials Rebrands from George Clinical

in clinical trials is underscored by a track record of repeat business, industry excellence awards, and consistent performance in bringing therapies to market. "For the past two decades, Emerald Clinical Trials has been focused on delivering high...

PBZ OTC, the First New Topical Antihistamine in 50 Years, Unveiled by Kingsway Pharmaceuticals at Target Stores Nationwide

often come with risks like drug interactions or steroid-related side effects. PBZ OTC changes that with a steroid-free formula gentle enough for children as young as two, yet strong enough for adults. Its unique ability to pair safely with oral...

IRBM Expands Functional Genomics Platform for Early Drug Discovery

Organization (CRO) specializing in preclinical drug discovery, has established a comprehensive Functional Genomics Platform to support genetic target identification and validation, and generation of disease-relevant cellular models. The platform...

PeptiGrowth Inc. Launches Novel Synthetic KGF Alternative Peptide (FGFR2b Agonist)

stem cells. Product Overview Product name: KGF alternative peptide (FGFR2b agonist) Product code: PG-012 Product form: Lyophilized Storage conditions: -20°C or less Purity: ≥95% by HPLC Molecular weight: 6018.40 (Acetate) Size: 10 μg, 100 μg, 1 mg...

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

areas of high unmet medical needs such as obesity/metabolism, oncology, and rare diseases. Hanmi leverages proprietary platform technologies, including long-acting biologics and bispecific antibodies, to address unmet medical needs. The company...

ELIQUENT Life Sciences Acquires Truliant Consulting, Expanding Pharmacovigilance Platform

knowledge, technology-driven approach, and operational scalability will expand ELIQUENT’s pharmacovigilance platform to offer clients a premier partner for regulatory success,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences....

Fast Company recognizes Bruin Biometrics as a top 10 innovative medical device maker

Bruin Biometrics LLC, a medical technology platform company that provides digital solutions for pressure injury prevention and management to health systems in the U.S. and U.K., announced it has been named by Fast Company as one of the World's 10...

Medline to launch a synthetic ligament augmentation implant.

foot and ankle orthopedic devices market insights, nearly 300,000 foot and ankle sports medicine procedures are performed in the U.S. each year, with ankle instability procedures representing approximately 44% of these surgical procedures. The...

Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera

According to Fernanda Bertasi, General Manager of Pint Pharma in Brazil, "ANVISA’s approval of BESREMi® represents a transformative milestone for patients with Polycythemia Vera in Brazil. This new therapeutic option brings real hope, offering...

Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

this strategic evolution underscores the Company’s true identity as the pioneer of NAD+ research and innovator behind transformative NAD-boosting healthy-aging solutions. At the forefront is Niagen Bioscience’s clinically proven, patented flagship...

Medit introduces SmartX, a new All-on-X solution for digital dentistry

dental clinics. About Medit: MEDIT is a global provider of 3D intraoral scanners and an all-in-one digital dentistry platform, based on its own patented state-of-the-art technology. The company also develops innovative software for digital...

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron. For more information, please visit: https://www.actiniumpharma.com/

Applications Are Being Accepted by the Vilcek Foundation from Immigrants Working in Biomedical Science

for the arts and sciences. The foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The foundation's mission was inspired by the couple's respective careers in biomedical science and art history....

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers and novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. Our continually evolving portfolio...

Fzata secures a clinical trial agreement for FZ002, targeting C. difficile treatment.

addition to advancing drug candidate safety and dosing, positive trial results will bolster confidence in the BioPYM platform as a groundbreaking therapeutics modality. No needle oral biologics with no cold-chain will transform the patient...